Fundz

Zegenex secures a $215,000 funding round from Richard King Mellon Foundation to enhance chronic wound treatments with Zegen-15, aiming for formulation optimization and preclinical testing.

PRIVATEDec 11, 2025

Amount Raised

$215,000

Round Type

Pre-Seed

PittsburghBiotechnologyHealth Care

Investors

Richard King Mellon Foundation

Description

Zegenex announced it has received a $215,000 social-mission investment from the Richard King Mellon Foundation. The funding will support formulation optimization and preclinical testing of Zegen-15, a small-molecule cream designed to treat chronic wounds. Chronic wounds like diabetic foot ulcers pose a significant medical challenge, affecting millions. The company aims to provide cost-effective solutions to improve patient outcomes.

Quick answer

Zegenex raised $215,000 in a Pre-Seed round, dated December 11, 2025. Investors: Richard King Mellon Foundation. Zegenex is based in Pittsburgh, Pennsylvania, United States.

How much did Zegenex raise?
Zegenex raised $215,000 in a Pre-Seed round on December 11, 2025.
Who invested in Zegenex?
Richard King Mellon Foundation is named as investors in this round.
What does Zegenex do?
Zegenex is a biotechnology company based in Pittsburgh that develops innovative therapies to accelerate wound healing.
Where is Zegenex based and how big is it?
Zegenex is based in Pittsburgh, Pennsylvania, United States. Fundz records about 2 employees.
Who are the decision-makers at Zegenex?
Fundz holds 1 contact at Zegenex, including the Co-Founder & CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Zegenex that raised within 45 days of this round, from Fundz verified event records.

  • Axogen raised $124M (Post-IPO Equity) on January 23, 2026.
  • Pi Health raised $8.6M on January 23, 2026.
  • Cancilico raised $2.9M (Seed) on January 22, 2026.
  • Mendra raised $82M (Series A) on January 22, 2026.
  • Corxel Pharmaceuticals raised $287M (Series D) on January 22, 2026.
  • Infinitopes raised $15M (Seed) on January 21, 2026.

Who to call at Zegenex, and when

A new round usually means Zegenex is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Zegenex raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Zegenex, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Zegenex. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Zegenex

Location

Pittsburgh, Pennsylvania, United States

About

Zegenex is a biotechnology company based in Pittsburgh that develops innovative therapies to accelerate wound healing. Its lead candidate, Zegen-15, is a small-molecule cream designed to reactivate the body’s natural healing processes in chronic wounds, such as diabetic foot ulcers. The company aims to provide a safe, effective, and cost-efficient alternative to traditional treatments. Zegenex combines cutting-edge science with a commitment to patient safety and affordability.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Zegenex raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsManush S., Co-Founder & CEOSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Zegenex's next move

See what Strategic adds

Zegenex raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.